Genmab — Marts 2024
-
Her er den snart 2 år gamle artikel i "Hæmatologisk tidsskrift" med Plesner om superdara https://haematologisktidsskrift.dk/sygdomme/myeloma/996-mere-effektiv-version-af-daratumumab-tyder-lovende-i-tidlige-forsog.html
-
Selv om en strategi er perfekt, skal man af og til kigge ud af vinduet, og se om den passer med virkeligheden
-
Surt, sødt, salt, bittert, umami - alle gode ting skal have balance
-
Ikke hvis du kigger på en value trap
-
Så længe du overvejer muligheden, min ven, så er jeg glad
-
…men GEN kan sagtens være moderen til alle value traps
-
Davrin - du er en vinder for mig. Men husk at være kritisk
-
Godmorgen
-
Successful treatment of scleromyxoedema with daratumumab https://twitter.com/BrJHaem/status/1773312588996079630
-
Pfizer stops one of two Phase 3 trials for sickle cell drug, still plans to seek approval in 2026 - inclacumab - https://endpts.com/pfizer-stops-one-of-two-phase-3-trials-for-sickle-cell-drug-still-plans-to-seek-approval-in-2026/
-
Kort video - Ugekommentar #122 Novo, Gubra, Zealand Pharma, Bavarian, Genmab, Ultimovacs, Anavex, Teva https://www.proinvestor.com/boards/119556
du tabte (altså i mit spil) 
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind